Healthcare Private Equity Market 2024: Year in Review and Outlook
In 2024, global healthcare private equity (PE) reached approximately $115 billion, driven by significant deal activity, particularly in North America,…
Pharma experts to gather at 13th International Conference on Pharmacy and Medicine at Sharjah Innovation Park from January 21
The 13th International Conference on Pharmacy and Medicine (ICPM 2025) will be held at the Sharjah Research, Technology, and Innovation…
The Digital Agriculture Mission, Approved On 02.09.2024 With A ₹2,817 Crore Budget
On August 28, 2024, the Government approved measures to expand the scope of AIF. These measures include the integration of…
Many Still Looking Away From Greystone Housing Impact Investors LP (NYSE:GHI)
Greystone Housing Impact Investors LP (NYSE:GHI) has a P/E ratio of 19.3x, slightly above the U.S. median of 18x, raising…
AI drives healthcare VC investment to $23 billion in 2024, SVB report shows
In 2024, healthcare venture capital investments reached $23 billion, a $3 billion increase from the previous year, driven by the…
Sprott Money Ltd. to Attend VRIC 2025: Showcasing Expertise in Precious Metals Investment
Sprott Money Ltd., a leading e-commerce platform for precious metals, will participate in the Vancouver Resource Investment Conference (VRIC) 2025…
Aditya Birla AMC Take on India and Global Economy 2025
The year 2025 is expected to bring macroeconomic turbulence in the U.S., influenced by Trump’s fiscal policies, including tax cuts…
Canada's Alphi Capital closes debut fund; GTCR, Genstar, Sun Capital and others …
Alphi Capital has successfully finalized fundraising for its inaugural fund , Alphi Capital I, securing $295 million in commitments from…
Three Policy Resets to Promote U.S. Innovation Leadership
Bipartisan consensus emphasizes the need to enhance U.S. innovation and technology leadership. However, federal agencies’ interventionist policies often overlook real…
State House News Service: Mass. Biopharma Sector Logs Increase In Venture Capital
In 2024, Massachusetts biopharma companies raised $7.89 billion in venture capital, a modest increase from 2023, according to a report…